Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

3.300

-0.280 (-7.82%)

At close: Mar 24, 2026, 4:00 PM EDT

3.350

+0.050 (1.52%)

After-hours: Mar 24, 2026, 7:35 PM EDT

Aclaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.96	24.57	39.88	45.28	27.35
Short-Term Investments	70.79	89.02	79.23	172.29	164.07
Cash & Short-Term Investments	90.75	113.59	119.11	217.57	191.41
Cash Growth	-20.11%	-4.63%	-45.26%	13.66%	253.61%
Accounts Receivable	5.57	12.36	0.3	0.48	0.62
Other Current Assets	-	-	9.45	13.5	13
Total Current Assets	96.32	125.95	128.86	231.55	205.03
Net Property, Plant & Equipment	0.76	1.01	1.62	1.1	1.34
Other Intangible Assets	-	-	-	6.97	7.05
Long-Term Investments	60.61	90.3	62.77	12.24	34.24
Other Long-Term Assets	2.77	3.07	4.16	2.73	3.55
Total Assets	160.46	220.33	197.41	254.6	251.21
Accounts Payable	13.16	4.69	8.88	10.35	9.99
Accrued Expenses	8.79	20.33	19.45	8.7	10.05
Current Portion of Leases	-	-	-	0.68	0.69
Unearned Revenue	3.94	3.89	-	-	-
Other Current Liabilities	2.75	2.68	2.63	2.2	2.2
Total Current Liabilities	28.65	31.6	30.95	21.94	22.93
Other Long-Term Liabilities	28.73	33.18	9.27	35.04	30.94
Total Long-Term Liabilities	28.73	33.18	9.27	35.04	30.94
Total Liabilities	57.38	64.77	40.23	56.98	53.87
Common Stock	0	0	0	0	0
Additional Paid-in Capital	1,070	1,058	928.08	880.83	792.97
Accumulated Other Comprehensive Income	0.61	0.1	-0.11	-0.9	-0.22
Retained Earnings	-967.78	-902.86	-770.8	-682.32	-595.41
Shareholders' Equity	103.08	155.55	157.18	197.62	197.34
Total Liabilities & Equity	160.46	220.33	197.41	254.6	251.21
Total Debt	0	0	0	0.68	0.69
Net Cash (Debt)	90.75	113.59	119.11	216.89	190.72
Net Cash Growth	-20.11%	-4.63%	-45.08%	13.72%	344.83%
Net Cash Per Share	0.74	1.47	1.71	3.33	3.36
Book Value	103.08	155.55	157.18	197.62	197.34
Book Value Per Share	0.84	2.01	2.25	3.03	3.48
Tangible Book Value	103.08	155.55	157.18	190.65	190.29
Tangible Book Value Per Share	0.84	2.01	2.25	2.92	3.35

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q